Items Tagged ‘Mediastinal Large B-Cell Lymphoma’

January 23, 2018

Keytruda Effective in Patients with Relapsed or Refractory Lymphoma

By

CancerConnect News: Findings from the KEYNOTE-170 clinical trial Presented at the 59th American Society of Hematology (ASH) Annual Meeting suggest that the novel immunotherapy medication keytruda® (pembrolizumab) represents a new treatment option for non-Hodgkin lymphoma. About Keytruda Keytruda is a monoclonal antibody that helps to restore the body’s immune system in fighting cancer. It creates its […]

View full entry

Tags: checkpoint inhibitor, keytruda, Mediastinal Large B-Cell Lymphoma, News, non-hodgkin lymphoma, Non-Hodgkin's Lymphoma, pembrolizumab, Precision Cancer Medicine